Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ

Name: Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ
Brand: MONARK BIOCARE PRIVATE LIMITED
Price: 108.0 INR
Availability: InStock

Price 108.0 INR/ Number

Get a Price/Quote

Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ Specification

Brand Name
Arkpime-T 281.25

Salt Composition
Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ

Life Span
24 Months

Packaging Type
281.25mg VIAL

Drug Type
Injection

Ingredients
Cefepime Hydrochloride 250 mg + Tazobactam Sodium 31.25 mg Injection is a sterile powder vial for reconstitution, combining fourth-generation cephalosporin cefepime (250 mg) with beta-lactamase inhibitor tazobactam (31.25 mg) in an 8:1 ratio for IV/IM use. Pediatric/neonatal strength targets serious bacterial infections including complicated UTI, pneumonia, intra-abdominal infections, sepsis, and skin/soft tissue infections by disrupting cell wall synthesis while inhibiting beta-lactamases (including ESBL producers).

Physical Form
Liquid

Quantity
1 Unit

Storage Instructions
cool & dry place

Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ Trade Information

Minimum Order Quantity
100 Number

Supply Ability
1000 Per Day

Delivery Time
5 Days

About Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ

Cefepime Hydrochloride 250mg + Tazobactam Sodium 31.25mg Injection is a sterile powder for reconstitution, combining the fourth-generation cephalosporin antibiotic cefepime with the beta-lactamase inhibitor tazobactam.
Cefepime disrupts bacterial cell wall synthesis by binding to penicillin-binding proteins, while tazobactam inhibits bacterial enzymes that degrade cefepime, broadening its spectrum against resistant strains including Gram-positive, Gram-negative, and some anaerobic pathogens.

Effective Against Resistant Bacterial Infections

Arkpime-T 281.25 combines cefepime and tazobactam to treat severe infections in pediatric and neonatal patients, including those caused by resistant bacteria such as ESBL producers. By combining a cephalosporin with a beta-lactamase inhibitor, it offers a dual mechanism to effectively combat infections that are difficult to treat with standard antibiotics.

Flexible Administration and Convenient Packaging

This product is supplied as a 281.25mg sterile powder vial. It can be reconstituted for intravenous or intramuscular injection, offering versatile administration based on the patient's needs. The thoughtfully designed vial ensures accurate dosing, while the packaging helps maintain sterility and potency over 24 months when stored in a cool, dry place.

FAQ's of Cefepime Hydrochloride 250mg +Tazobactum Sodium 31.25MG INJ:

Q: How is Cefepime Hydrochloride 250mg + Tazobactam Sodium 31.25mg INJ administered?

A: This medicine is intended for intravenous (IV) or intramuscular (IM) injection. The sterile powder is first reconstituted with a suitable diluent by a healthcare professional before administration.

Q: What types of infections does Arkpime-T 281.25 treat?

A: It is used to manage serious bacterial infections in pediatric/neonatal patients, including complicated urinary tract infections, pneumonia, intra-abdominal infections, sepsis, and skin or soft tissue infections.

Q: When should this injection be used?

A: Arkpime-T 281.25 should be used when your doctor has identified or suspects bacterial infections that may not respond well to standard antibiotics, especially those caused by resistant organisms.

Q: Where should the vials be stored?

A: Store the vials in a cool and dry place, away from direct sunlight, to preserve the medication's efficacy for up to 24 months.

Q: What is the process for preparing the injection?

A: A healthcare professional will reconstitute the powder in the vial using a prescribed diluent, ensuring it is fully dissolved before administering via IV or IM route as instructed by your doctor.

Q: How does the combination of cefepime and tazobactam benefit treatment?

A: Cefepime disrupts bacterial cell wall synthesis, while tazobactam inhibits beta-lactamase enzymes (including ESBL), helping to prevent resistance and extend the antibiotic's spectrum of activity.

Tell us about your requirement